Target intelligence / Profile preview

Foot-and-Mouth Disease Virus capsid protein VP2 (VP2)

Target
VP2
Molecular classification
Viral capsid protein, Picornavirus structural protein
01

Overview

The Foot-and-Mouth Disease Virus (FMDV) VP2 capsid protein, also known as P1B, is a vital structural component of the FMDV virion, a member of the Picornaviridae family. It forms the icosahedral capsid along with VP1, VP3, and VP4, with VP2 specifically contributing to the outer shell and the stability of the viral particle. VP2 is essential for the assembly of the virus, participating in the formation of pentameric subunits that encapsulate the viral RNA. In addition to its structural function, VP2 has been identified as a modulator of host cell processes, such as the induction of autophagy through the EIF2S1-ATF4 pathway to promote viral replication. Due to its exposure on the virion surface, VP2 is a primary target for neutralizing antibodies and is a critical component in the design of inactivated and recombinant vaccines. However, the high mutation rate of FMDV leads to significant antigenic variation in VP2, necessitating the development of serotype-specific vaccines and complicating global control efforts.

Other names
P1BVirion protein 2Capsid protein VP2
02

Mechanism of action

Vaccines containing or expressing the VP2 protein induce the production of neutralizing antibodies that bind to the viral capsid, thereby preventing host cell attachment, entry, and uncoating. Experimental therapeutic strategies also focus on blocking VP2-mediated autophagy or disrupting the assembly of the viral capsid to inhibit viral replication.

03

Biological functions

Viral capsid assemblyHost cell entryInduction of autophagyAntigenicityViral genome encapsidation
04

Disease associations

Foot-and-mouth diseaseInfection
05

Safety considerations

Antigenic variation and serotype-specific immunityVaccine escape due to rapid mutationThermostability of capsid-based vaccinesRisk of incomplete inactivation in traditional vaccines
06

Interacting drugs

Inactivated Foot-and-Mouth Disease Virus vaccine

3 more in the full profile.

07

Biomarkers

Anti-VP2 antibodiesFMDV RNAVP2 antigen

Beyond the preview

Go deeper on Foot-and-Mouth Disease Virus capsid protein VP2 (VP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foot-and-Mouth Disease Virus capsid protein VP2 (VP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call